Janney Montgomery Scott LLC Exact Sciences Corp Transaction History

Janney Montgomery Scott LLC

  • $38.3 Billion
  • Q2 2025

A detailed history of Janney Montgomery Scott LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 34,734 shares of EXAS stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,734
Holding current value
$1.68 Million
% of portfolio
0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025
BUY
$40.31 - $58.08 $1.4 Million - $2.02 Million
34,734 New
34,734 $1.85 Million
Q4 2024

Jan 17, 2025
BUY
$49.33 - $71.97 $6,610 - $9,643
134 Added 3.02%
4,573 $257,000
Q3 2024

Oct 29, 2024
BUY
$42.43 - $70.83 $188,346 - $314,414
4,439 New
4,439 $302,000
Q1 2024

May 01, 2024
SELL
$56.27 - $73.77 $406,607 - $533,062
-7,226 Reduced 48.49%
7,675 $530,000
Q4 2023

Feb 07, 2024
BUY
$59.06 - $75.72 $44,826 - $57,471
759 Added 5.37%
14,901 $1.1 Million
Q3 2023

Nov 08, 2023
BUY
$65.94 - $99.04 $31,914 - $47,935
484 Added 3.54%
14,142 $965,000
Q2 2023

Jul 26, 2023
SELL
$62.68 - $95.05 $97,216 - $147,422
-1,551 Reduced 10.2%
13,658 $1.28 Million
Q1 2023

Apr 28, 2023
BUY
$47.19 - $70.77 $180,690 - $270,978
3,829 Added 33.65%
15,209 $1.03 Million
Q4 2022

Feb 01, 2023
BUY
$30.35 - $53.15 $65,343 - $114,431
2,153 Added 23.33%
11,380 $563,000
Q3 2022

Oct 25, 2022
SELL
$31.97 - $49.37 $147,125 - $227,200
-4,602 Reduced 33.28%
9,227 $300,000
Q2 2022

Aug 03, 2022
SELL
$35.61 - $76.23 $72,964 - $156,195
-2,049 Reduced 12.9%
13,829 $569,000
Q1 2022

May 04, 2022
BUY
$57.56 - $82.54 $178,320 - $255,708
3,098 Added 24.24%
15,878 $1.11 Million
Q4 2021

Jan 27, 2022
BUY
$72.5 - $100.68 $123,612 - $171,659
1,705 Added 15.4%
12,780 $995,000
Q3 2021

Oct 29, 2021
SELL
$90.24 - $124.05 $311,959 - $428,840
-3,457 Reduced 23.79%
11,075 $1.06 Million
Q2 2021

Jul 26, 2021
BUY
$93.66 - $139.27 $85,136 - $126,596
909 Added 6.67%
14,532 $1.81 Million
Q1 2021

Apr 27, 2021
SELL
$116.57 - $155.01 $151,074 - $200,892
-1,296 Reduced 8.69%
13,623 $1.8 Million
Q4 2020

Jan 25, 2021
BUY
$99.61 - $142.12 $696,074 - $993,134
6,988 Added 88.11%
14,919 $1.98 Million
Q3 2020

Nov 06, 2020
SELL
$72.92 - $102.01 $78,389 - $109,660
-1,075 Reduced 11.94%
7,931 $809,000
Q2 2020

Jul 23, 2020
BUY
$55.75 - $92.75 $23,024 - $38,305
413 Added 4.81%
9,006 $783,000
Q1 2020

Apr 30, 2020
SELL
$37.9 - $104.44 $54,007 - $148,827
-1,425 Reduced 14.22%
8,593 $498,000
Q4 2019

Jan 21, 2020
BUY
$77.66 - $99.74 $70,748 - $90,863
911 Added 10.0%
10,018 $926,000
Q3 2019

Oct 29, 2019
SELL
$90.37 - $122.49 $994 - $1,347
-11 Reduced 0.12%
9,107 $823,000
Q2 2019

Jul 29, 2019
BUY
$89.51 - $118.04 $8,324 - $10,977
93 Added 1.03%
9,118 $1.08 Million
Q1 2019

Apr 30, 2019
SELL
$61.98 - $96.5 $55,472 - $86,367
-895 Reduced 9.02%
9,025 $782,000
Q4 2018

Feb 01, 2019
BUY
$56.04 - $82.66 $253,637 - $374,119
4,526 Added 83.91%
9,920 $626,000
Q3 2018

Nov 05, 2018
BUY
$48.29 - $80.6 $260,476 - $434,756
5,394 New
5,394 $426,000
Q2 2018

Jul 24, 2018
SELL
$37.84 - $69.96 $257,198 - $475,518
-6,797 Closed
0 $0
Q1 2018

Apr 19, 2018
SELL
$39.82 - $57.53 $806,355 - $1.16 Million
-20,250 Reduced 74.87%
6,797 $274,000
Q4 2017

Feb 14, 2018
SELL
$46.49 - $60.51 $308,275 - $401,241
-6,631 Reduced 19.69%
27,047 $1.42 Million
Q3 2017

Nov 15, 2017
BUY
$37.05 - $47.12 $1.25 Million - $1.59 Million
33,678
33,678 $1.59 Million

Others Institutions Holding EXAS

# of Institutions
644
Shares Held
157M
Call Options Held
1.83M
Put Options Held
1.56M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.58B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email